Benchmark Maintains Buy on Prenetics Global, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 66.5%

Neg 0% Neu 0% Pos 66.5%

Benchmark analyst Bill Sutherland maintains Prenetics Global (NASDAQ:PRE) with a Buy and raises the price target from $30 to $40.